Adeza Joins Russell 2000 and Russell 3000 Indexes
April 7, 2005
SUNNYVALE, Calif.--(BUSINESS WIRE)--April 7, 2005--Adeza (NASDAQ:ADZA), a women's health company and the sole provider of a unique test for use in assessing the risk of preterm birth, today announced that it has been added to the Russell 2000® and Russell 3000® Indexes, effective after the close of U.S. equity markets on March 31, 2005.
"We welcome the addition of Adeza to the Russell Indexes as we believe that membership in the Russell Indexes will contribute to additional investor awareness of our Company," said Emory V. Anderson, president and chief executive officer of Adeza.
Russell produces a family of 21 U.S. equity indexes which is designed to be a comprehensive representation of the investable U.S. equity market. Index membership is determined by market capitalization rankings and style attributes. Only common stocks incorporated in the United States and its territories are included. Beginning September 30, 2004, Russell Indexes began adding initial public offerings on a quarterly basis in order to enhance how well each index reflects its segment of the U.S. equity market. Adeza was one of 39 companies added to the Russell 2000 and 3000 Indexes at the close of the 2005 first quarter, six of which were in the healthcare sector.
About Adeza
Adeza designs, manufactures and markets innovative products for women's health. Adeza's initial focus is on reproductive healthcare, using its proprietary technologies to predict preterm birth and assess infertility. Adeza's principal product is a patented diagnostic test, Full Term ™ - The Fetal Fibronectin Test, which utilizes a single-use, disposable cassette and is analyzed on Adeza's patented TLiIQ® System. This product is approved by the U.S. Food and Drug Administration (FDA) for broad use in assessing the risk of preterm birth. Adeza also markets and sells the E-tegrity® Test, an infertility-related test to assess receptivity of the uterus to embryo implantation in women with unexplained infertility. More information is available at www.adeza.com.
Adeza cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Adeza that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Adeza's business including, without limitation, statements about the expansion of the indications for its products. All forward-looking statements are qualified in their entirety by this cautionary statement and Adeza undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.